Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2013 Aug;79(16):4958–4964. doi: 10.1128/AEM.01134-13

Sequence Variability of P2-Like Prophage Genomes Carrying the Cytolethal Distending Toxin V Operon in Escherichia coli O157

Domonkos Sváb a, Balázs Horváth a, Gergely Maróti b, Ulrich Dobrindt c, István Tóth a,
PMCID: PMC3754688  PMID: 23770900

Abstract

Cytolethal distending toxins (CDT) are potent cytotoxins of several Gram-negative pathogenic bacteria, including Escherichia coli, in which five types (CDT-I to CDT-V) have been identified so far. CDT-V is frequently associated with Shiga-toxigenic E. coli (STEC), enterohemorrhagic E. coli (EHEC) O157 strains, and strains not fitting any established pathotypes. In this study, we were the first to sequence and annotate a 31.2-kb-long, noninducible P2-like prophage carrying the cdt-V operon from an stx- and eae-negative E. coli O157:H43 strain of bovine origin. The cdt-V operon is integrated in the place of the tin and old phage immunity genes (termed the TO region) of the prophage, and the prophage itself is integrated into the bacterial chromosome between the housekeeping genes cpxP and fieF. The presence of P2-like genes (n = 20) was investigated in a further five CDT-V-positive bovine E. coli O157 strains of various serotypes, three EHEC O157:NM strains, four strains expressing other variants of CDT, and eight CDT-negative strains. All but one CDT-V-positive atypical O157 strain uniformly carried all the investigated genomic regions of P2-like phages, while the EHEC O157 strains missed three regions and the CDT-V-negative strains carried only a few P2-like sequences. Our results suggest that P2-like phages play a role in the dissemination of cdt-V between E. coli O157 strains and that after integration into the bacterial chromosome, they adapted to the respective hosts and became temperate.

INTRODUCTION

Cytolethal distending toxins (CDT) are considered prototypic inhibitory cyclomodulins (1, 2). Genes encoding CDTs are widely disseminated among Gram-negative pathogenic bacteria, including Escherichia coli, Campylobacter spp., Aggregatibacter actinomycetemcomitans, Haemophilus ducreyi, Salmonella enterica serovar Typhimurium, and Shigella spp. (3).

The holotoxin is a heterotrimer of three protein subunits, CdtA, CdtB, and CdtC. These are encoded by three adjacent, sometimes slightly overlapping genes (4). CdtB is the active subunit, possessing DNase activity and sharing homology with the mammalian DNase I (5). There is evidence that in case of Campylobacter spp., A. actinomycetemcomitans, and H. ducreyi, the other two subunits play a role in the transport of CdtB into the target cell (3). Upon entering the eukaryotic cell, CdtB causes DNA damage, which in turn causes cell cycle arrest between the G2 and M phases (6). Double-stranded DNA damage leads to the distension and subsequent death of the target cell (7). The characteristic distending transformation has been demonstrated on multiple cell lines by several studies (7, 8).

CDT was first identified in E. coli (Johnson and Lior) (9), and its production has been associated with several pathotypes, e.g., enterohemorrhagic (EHEC) and enteropathogenic (EPEC) (3). So far, five types have been associated with E. coli, termed CDT-I to CDT-V (4, 6, 10, 11, 12). The genomic localization of cdt alleles and their association with mobile genetic elements was reported by several groups. Accordingly, Pérès et al. localized cdt-III to a large conjugative virulence plasmid (6). cdt-I and cdt-IV are encoded by lambdoid prophages (13, 14), while the cdt-V operon is flanked by P2-like phage sequences (11, 14, 15, 16), but the corresponding nucleotide sequences deposited show only small portions of the phage genes repA (replication gene A) and Q (a capsid gene).

The presence of CDT-V in Shiga-toxigenic E. coli (STEC) strains of various serotypes, both of clinical (17, 18) and nonclinical (19) origin, has been reported. CDT-V has also been associated with strains of other serotypes and pathotypes associated with human diarrhea (16, 20), where it is the only known cytotoxin of the respective strains, underlining the importance of CDT-V as a virulence factor. Therefore, it is imperative to obtain more information on the potential mobility of the CDT-V-encoding operon in non-STEC pathotypes and determine whether it is phage associated.

The aim of this study was to characterize the P2-like phage sequence context flanking the cdt-V operon in strain T22, an E. coli O157:H43 strain of atypical pathotype (eae and stx negative), and to monitor the presence of characteristic regions in other pathogenic and nonpathogenic CDT-V-positive strains and in additional K-12 E. coli strains.

MATERIALS AND METHODS

Bacterial strains.

Strains used in this study are listed in Table 1. Strains were grown on lysogeny broth (LB) agar plates or bromothymol blue agar plates.

Table 1.

Bacterial strains used in this study and the presence of P2-like genes and regions in each of them

Strain Serotype Pathotypec CDT type Phylogenetic groupd Presence/absenceb of:
Reference
Spacer Q Spacer cdtA spacer cdtc-repA P P-Q repA repA distant C O Short ORFs Baseplate J Tail Terminase D FI Capsid Lysin cpxP integrase ogr-fieF
T22a O157:H43 Atypical V B1 + + + + + + + + + + + + + + + + + + + + 23
T16a O157:H43 Atypical V B1 + + + + + + + + + + + + + + + + + + + 23
T50a O157:H43 Atypical V B1 + + + + + + + + + + + + + + + + + + + 23
T34a O157:H9 Atypical V B1 + + + + + + + + + + + + + + + + + + 23
T49a O157:H37 Atypical V B1 + + + + + + + + + + + + + + + + + + 23
T4 O157:H12 Atypical A 23
B20 O157:H12 Atypical A 23
B47 O157:NM Atypical B1 + + + + + + + + + + + + + + 23
B54 O157:H12 Atypical A 23
E6468/62 O86:H34 EPEC I ND 4
BM2-10 O88 Diarrheagenic III ND + + 35
28C O75:K95 ExPEC IV ND + + + + + + + + + + + 14
703/88a O157:NM EHEC V D + + + + + + + + + + + + + + + 14
702/88a O157:NM EHEC V D + + + + + + + + + + + + + + + 14
493/89a O157:NM EHEC V D + + + + + + + + + + + + + + + + 36
E2348/69 O127:H6 EPEC B2 37
Sakai O157:H7 EHEC D 38
C600 K-12 Commensal ND + 39
ER2738 K-12 Commensal ND + + 40
a

Strain was used in the phage induction experiments.

b

“Spacer” refers to the region between cdtA and capsid packaging protein gene Q, which has no associated function so far. “Short ORFs” refers to the region spanning 4 ORFs from a replication gene (repB) to a hypothetical zinc finger protein. +, presence; −, absence.

c

EPEC, enteropathogenic Escherichia coli; EHEC, enterohemorrhagic Escherichia coli; ExPEC, extraintestinal pathogenic Escherichia coli.

d

ND, not determined.

Cosmid clone library construction and screening.

Genomic DNA was isolated from strain T22 of E. coli O157:H43 with the Sigma genomic DNA kit (Sigma-Aldrich, St. Louis, MO). The preparation of the cosmid clone library was performed with the pWEB-TNC cosmid cloning kit (Epicentre, Madison, WI) according to the manufacturer's instructions, with the modification that genomic DNA was subjected to a partial digestion with restriction endonuclease MboI (Fermentas, Vilnius, Lithuania). All together, 1,000 transformant colonies were identified (cosmid library) and screened for the presence of cdt-V using the primers indicated in Table 2.

Table 2.

Primers used for the investigation of P2-like regions

Primer name Target gene(s) Sequence 5′ to 3′ Position (bp)a Reference
FI_fw Tail sheath monomer FI gene TGCGTGTGGAAGACGGCACC 24612–24631 This study
FI_rev CGGCCTTGAGGGTTTCCGCAT 25413–25433 This study
Latecontrol_D_fw Late control protein D gene TTCGTGGCGCTGTCCTGACG 29694–29713 This study
Latecontrol_D_rev TGGAGAACTCCGCAACGCCC 30448–30467 This study
Terminase_fw Terminase gene GGGAGCCGAACGGATTGGCG 10561–10580 This study
Terminase_rev CTTGAGCACCGCATCCGCGA 11298–11317 This study
Capsid_fw Capsid gene CCGTCGGTCACCCAGACCCT 12975–12994 This study
Capsid_rev AGCGGCCAGCATTTCGCTGT 13655–13636 This study
Lysin_fw Lysin gene ATGCTGGCCGTGTCCGAAGG 15834–15853 This study
Lysin_rev CTGACCGTAACCGGCACCCG 16204–16223 This study
Tail_protein_fw Phage tail gene AGGGCGCTGACTGATGCCGT 17271–17290 This study
Tail_protein_rev AGCTCCATCGGGCGGGTGAC 17655–17674 This study
Baseplate_J_fw Baseplate gene J GGTTGCCCGTACCCTGACGC 19335–19354 This study
Baseplate_J_rev GACAGACGGATGTCGCGCCC 19960–19979 This study
L413C_specific_fw C (repressor) AGGATCCAGCCCTTTCTAAA 1632–1651 This study
L413C_specific_rev AATCCTTTTCGCGGAGTGG 1243–1261 This study
gpO_fw Capsid scaffolding protein O gene TTTCGTATCGGCGTTGAGG 11984–12002 This study
gpO_rev TGTTTTTCAGGCGGGTGAA 12710–12728 This study
cpxP2_fw cpxP integrase gene AGCCATATGTTCGACGGCAT 4327924–4327943* This study
integrase_rev AGGCCAGCGCCAAATTATTC 439–458 This study
P2_cdta_up_novel_fw Spacer region gene CCAAGAGCACGCCAGCACTGA 8727–8747 This study
P2_cdta_up_novel_rev TGGCAAATCTCCTTTGGGCTAGTG 8261–8284 This study
Cdta_up_novel_overlap_fw cdtA spacer gene TCAATCGCGTTTTGCACTCACGG 8500–8522 This study
Cdta_up_novel_overlap_rev AGGTCCAGCCCCGGGTAATGG 8018–8038 This study
P2_novel_overlap_fw Capsid packaging protein Q spacer gene ACAAGGGAAAGCCGACGGCAT 9259–9279 This study
P2_novel_overlap_rev TCAGTTATCGTCAGTGCTGGCGTGC 8717–8741 This study
Cdtc_P2_overlap_fw cdtC replication gene A CATACCTTCAACAACAGGTGCGGT 6227–6250 This study
Cdtc_P2_overlap_rev TACCGGTTCCCACGCCTTCTG 5591–5611 This study
P2_short_orfs_fw Short ORFs CGCCGTCAGGTTGGCGCAA 2367–2385 This study
P2_short_orfs_rev AACCAGCGCAGAAGCACCGC 3281–3300 This study
ogr_fw ogr-fieF ACGTGAATTGCAGCGCCACG 30840–30859 This study
fieF_rev CCAGCGCCAGCAGAATTGCG 4361610–4361629* This study
P2_PQ_fw Capsid packaging protein Q gene AACACCGCAACCTGCGGCAA 9974–9993 This study
P2_PQ_rev CCACCAGTAAACATCCTCT 9579–9597 This study
P2_P_fw Terminase protein P gene AACCTGTTCATGTGTGAA 10676–10693 This study
P2_P_rev AACGAGCTGGTGATGTCGG 10191–10209 This study
P2_repA_fw Replication gene A TTTCGATAATCTGGTTACG 4915–4933 This study
P2_repA_rev TATGGTCATGTTGCTGGCGC 4213–4232 This study
P2_repA_ext_fw Replication gene A distant region TTGCTTCAAAGACTGACTG 3376–3394 This study
P2_repA_ext_rev GAAATGAACGACGTCGAACGT 2298–2318 This study
CDT-IIIs cdt-VB GAAAGTAAATGGAATATAAATGTCCG 7291–7316 11
CDT-IIIas TTTGTGTCGGTGCAGCAGGGAAAA 6761–6784 11
a

The reference sequence for the primers indicated with an asterisk is CP002967 (whole genome of Escherichia coli strain W). Positions are given in reference to GenBank accession number KC618326.1, except where indicated otherwise.

Sequencing.

Cosmid DNA was isolated by using the alkaline lysis method (21), genomic DNA was isolated by using the GenElute bacterial genomic DNA kit (Sigma-Aldrich, St. Louis, MO), and both were sequenced at the Biological Research Center (Szeged, Hungary) by using the Ion Torrent Personal Genome Machine (PGM) next-generation sequencer as well as traditional Sanger-based capillary sequencing. The average coverage for the prophage region was 112×. Trimming and assembly were performed manually and by using CLC Genomics Workbench version 6.0.1. Nucleotide sequence analysis and searches for open reading frames (ORFs) and homologous DNA sequences in the EMBL and GenBank database libraries were performed with the tools available from the National Center for Biotechnology Information (www.ncbi.nlm.nih.gov) together with Vector NTI and CLC Bio Genomics Workbench softwares.

PCR screening for flanking regions.

E. coli strains representing different serotypes and pathotypes (Table 1) were tested by PCR for the presence of characteristic P2-like phage genes. Primers were designed with the aid of PrimerBLAST, available from the National Center for Biotechnology Information. The general PCR conditions were an initial denaturation of 3 min at 94°C and then 30 cycles of denaturation for 30 s at 94°C, followed by annealing for 30 s at 59 to 60°C (depending on the primer pair) and extension for 60 s at 72°C. The final extension time was 5 min. The primers used in the reactions are listed in Table 2.

Phage induction experiments.

Phage induction was carried out for the 8 strains marked in Table 1, using either mitomycin C (0.5 μg ml−1) or norfloxacin (1.25 μg ml−1) as inducing agents. Induction was also attempted by UV irradiation as described by Hertman and Luria (22), with the modification that doses were 15, 10, and 5 s long with a 30-W lamp. E. coli K-12 strains ER2738, C600, and Shigella sonnei strain 866 (19), kindly provided by Maite Muniesa, were used as indicator strains. As a positive control for phage induction, the E. coli O157:H7 strain 34, harboring an inducible Stx2 phage (23), was used.

Nucleotide sequence accession number.

The nucleotide sequence of the P2-like prophage has been deposited into GenBank (KC618326.1).

RESULTS

Characteristics of the P2-like prophage carrying the cdt-V cluster.

In order to determine the sequence of the cdt-V operon and its exact position in the genome of E. coli O157:H43 strain T22, a clone of the cosmid library positive for cdt-V, as well as the corresponding region of the genomic DNA, was sequenced, annotated, and deposited into GenBank. The length of the prophage containing the cdt-V operon is 31.2 kb. The cdt-V operon of strain T22 shows the highest nucleic acid similarity to the cdt operon of strain AH-10 (GenBank no. AB472839). The sequence of cdtB, coding for the active toxin subunit, is highly homologous to the AH-10-specific sequence, with only 4 synonymous single-nucleotide polymorphisms (SNPs). The CDT-V-encoding operon in strain T22 is flanked by P2-like prophage sequences. The majority of P2-like genes carried by T22 have the highest similarity to the bacteriophage L-413C (97% similarity on average at the nucleotide level; GenBank no. AY251033). The GC content of the cdt-V operon is 41%, whereas the prophage genes exhibit an average GC content of 53%. The structural organization of the P2-like phage genes is reminiscent of the P2-like prophage in E. coli strain W (GenBank no. CP002967). DNA sequence comparison between the P2-like sequences of strains T22 and W revealed that there is a high degree of nucleotide homology (94 to 99% identity) between their genes (Table 3). The tail fiber-encoding genes (ORFs 33 to 36) located in the region ranging from bp positions 20720 to 23571 are different from all published P2-like prophages. The respective phage tail fiber genes of the prophage in the genome of E. coli strain UMNK88 (accession no. CP002729; with the homologue of ORF 34 being present in two copies) are their closest homologues, with a nucleotide identity of 92 to 99%. The region between bp positions 22000 and 22192 is entirely missing in all other P2-like prophage sequences available in GenBank, whereas it is present in the prophage of UMNK88. The ORFs predicted in the P2-like prophage of E. coli O157 strain T22 are listed in Table 3.

Table 3.

Functional annotation of the P2-like prophage in E. coli O157:H43 strain T22a

ORF Feature or product of sequence Position
Size (bp) No. of identical nt/total no. of nt, % identity Reference accession no. Strain
Start End
1 Integrase 187 1167 981 980/981, 99 CP002797.2 NA114
2 Immunity repressor 1237 1530 294 294/294, 100 AY251033.1 Bacteriophage L-413C
3 Repressor, prophage excision 1667 1939 273 273/273, 100 CP002797.2 NA114
4 Unknown 1915 2112 198 196/198, 99 CP002797.2 NA114
5 DNA replication 2109 2609 501 501/501, 100 CP001368.2 TW14359
6 Unknown 2673 2897 225 223/225, 100 CP000800.1 E24377A
7 Unknown 2897 3199 303 290/303, 96 CP002967.1 W
8 Hypothetical zinc finger protein 3199 3423 225 221/225, 98 CP002185 W
9 Unknown 3420 3695 276 274/276, 99 CP002967.1 W
10 DNA replication 3685 5982 2,298 2191/2262, 97 CP002185 W
11 Cytolethal distending toxin C subunit 6058 6603 546 545/546, 99 AB472839 AH-10
12 Cytolethal distending toxin B subunit 6618 7427 810 809/810, 99 AB472860 AH-16
13 Cytolethal distending toxin A subunit 7424 8200 777 777/777, 100 JF461073 Bacteriophage fi125
14 Hypothetical protein 8779 8940 162 161/162, 99 AB472870 AH-26
15 Phage-related capsid packaging protein 8979 10013 1,035 1009/1035, 97 CP000970 SMS-3-5
16 Phage terminase, ATPase subunit 10014 11786 1,773 1724/1774, 97 AY251033.1 Bacteriophage L-413C
17 Phage capsid scaffolding protein 11894 12814 921 896/921, 97 CP002185 W
18 Phage major capsid protein 12873 13946 1,074 1060/1074, 97 CP002185 W
19 Phage terminase, endonuclease subunit 13951 14693 744 727/744, 98 AJ298566.1 Bacteriophage 299
20 Phage head completion, stabilization 14793 15302 510 499/510, 98 CP000970 SMS-3-5
21 Phage tail completion protein 15302 15505 204 202/204, 99 AY251033.1 Bacteriophage L-413C
22 Phage holin 15544 15789 246 246/246, 100 AY251033.1 Bacteriophage L-413C
23 Phage lysin 15789 16286 498 492/498, 99 CP002967.1 W
24 Phage holin, endolysin 16301 16726 414 420/426, 99 CU928161 S88
25 Phage spanin, Rz 16714 17139 426 412/426, 97 CP000970 SMS-3-5
26 Phage outer membrane lipoprotein 17126 17284 159 157/159, 99 CP002967.1 W
27 Phage tail protein 17247 17714 468 461/468, 99 CP002967.1 W
28 Phage tail completion protein 17707 18159 453 441/453, 97 CP002967 W
29 Baseplate assembly 18226 18861 636 622/636, 98 CP002967.1 W
30 Baseplate assembly 18858 19205 348 342/348, 98 CU928162 ED1a
31 Baseplate assembly 19210 20118 909 890/909, 98 CP001969 IHE3034
32 Phage tail fiber 20111 20722 612 603/612, 99 CP001368 TW14359
33 Phage tail fiber 20719 22218 1,500 1437/1502, 96 CP002729 UMNK88
34 Putative tail fiber assembly protein 22218 22820 603 595/603, 99 CP002729 UMNK88
35 Tail fiber assembly protein 22792 23235 444 433/444, 98 CP001368 TW14359
36 Hypothetical protein 23256 23570 315 289/315, 92 CP002729 UMNK88
37 Phage DNA invertase 23713 24207 495 468/499, 94 CP002967 W
38 Phage tail sheath protein 24362 25552 1,191 1173/1191, 98 HE616528 Shigella sonnei 53G
39 Phage tail tube protein 25565 26083 519 518/519, 99 CU928161 S88
40 Tail protein 26140 26415 276 267/276, 97 CP002516 KO11
41 Putative phage tail protein 26412 26567 156 156/156, 100 CP004009 APEC O78
42 Phage protein 26560 29007 2,448 2390/2448, 98 CU928162 ED1a
43 gpU (tail protein) 29022 29501 480 471/480, 98 CP002967 W
44 Gene D protein 29501 30664 1,164 1137/1164, 98 CU928161 S88
45 Putative positive regulator of lysis 30671 30964 294 288/294, 98 CP000970 SMS-3-5
a

Positions refer to GenBank accession number KC618326.1. Homologies of 100% are in bold.

PCR scanning of P2-like genes.

The dissemination of characteristic cdt-V-flanking genes (n = 20) in a collection of CDT-producing and nonproducing strains was examined by PCR. At least one gene from each P2-like functional gene cluster was investigated. The list of results, together with the genotype of the strains, is given in Table 1. Fifteen out of 20 primer pairs designed specifically for the flanking regions (Table 2) yielded PCR products in all CDT-V-positive strains. The overlapping primer pairs covering the Q capsid gene and the spacer region between the Q gene and cdtA yielded only a PCR product in the O157:H43 strains tested, and the tail sheath monomer-encoding FI gene could be amplified only from strain T22 and the O157:NM CDT-V strains. Strains carrying different cdt types and the CDT-negative strains carried fewer P2-like genes. Interestingly, the CDT-negative atypical strain B47 and the CDT-IV-positive strain 28C were positive for 15 and 12 of the investigated sequences, respectively. Sequencing of the amplicons produced by the P2_PQ primer pair (Table 2) showed that in this 376-bp region of the Q capsid gene, there was a maximum of 14 SNPs, with only 3 of them leading to amino acid changes.

Phage induction experiments from CDT-V-positive strains.

In order to induce lysogenic bacteriophages and to isolate corresponding phage particles from the CDT-V-positive strains, phage induction experiments were carried out with 8 CDT-V-positive strains, marked in Table 1, by using UV light as well as mitomycin C and norfloxacin as inducing agents. Among CDT-V-positive strains, only EHEC O157:NM strains 702/88 and 493/89 released phages upon induction with mitomycin C, which were able to infect and lyse E. coli strain C600. PCR investigations revealed that none of these phages carried cdt-V genes (data not shown). These data indicate that the P2-like prophages harboring the cdt-V operon cannot be induced from these stx-negative and cdt-V-positive E. coli O157 strains.

DISCUSSION

We sequenced for the first time a whole P2-like prophage from the genome of E. coli O157:H43 strain T22 containing a cdt-V operon. The cdt-V sequence in strain T22 is highly similar to that of the cdt-V operon in strain AH-10 (16). Our results confirm and expand our knowledge based on previous reports that the cdt-V operon is flanked by P2-like phage sequences (12, 16) and on a more recent finding of an inducible P2-like phage carrying the cdt-V operon (19). The proximal P2-like regions in E. coli T22 are highly similar to the sequences published by the above-mentioned authors; however, in our study, the entire prophage genome was resolved and annotated. Among the lytic P2-like bacteriophages, phage L-413C (induced originally from a Yersinia pestis strain [24, 25]) has the highest homology compared to the prophage sequence of strain T22 (GenBank no. AY251033). Among other available prophage sequences, the P2-like prophage of E. coli O157:H7 strain TW14359 (GenBank no. CP001368.1) is the closest homologue. Compared to all the P2-like prophage sequences available in GenBank, the level of homology between the individual structure genes and their closest homologues is between 94 and 100% (Table 3). The Z/fun region in the original P2 phage, situated between the tail fiber gene G and the tail sheath gene FI, is known to host insertions of foreign genes (26). In the case of strain T22, the P2-like prophage does not contain a gene homologous to the G gene. Instead, the tail fiber genes between bp positions 20720 and 23571 (ORFs 33 to 36; see Table 3) seem to have a different origin in this strain, as they show only partial homology to P2-like phages or prophages, their closest homologues being tail fiber genes of a prophage carried by E. coli strain UMNK88. Among the flanking ORFs, ORF 32 corresponds to gene H (upstream of G) and ORF 37 to gene FI; therefore, the insertion of ORFs 33 to 36 occurred essentially in the Z/fun region, with the additional deletion of gene G. Nilsson and coworkers suggested site-specific recombination as a possible mechanism for the insertion of foreign genes in this region (27). The potential recombination of prophages in E. coli O157 was already reported (28), and it was also suggested that the mosaic structure of prophages is the result of extensive exchange of genetic material among different bacteriophages and also their hosts (13), like in the case of lambdoid prophages harboring the cdt-I and cdt-IV operons (13, 14). The genome sequencing project of strain T22 (29) confirmed that the integration site of the prophage is between the cpxP and fieF genes. This is the same site where P2-like prophages can be found in a further four E. coli strains according to publicly available GenBank entries (accession no. CP002967.1, CP002797.2, CP001969.1, and CP000970.1).

The integration site of the cdt-V operon within the prophage, the TO region, is known to be an integration hot spot for foreign genes in P2-like phages (26). This region is named after the phage immunity genes tin and old, encoded by the lytic phages in this region. It has been suggested that this site is a potential carrier of advantageous genes for the host (26). The carriage of a potent virulence-associated gene, like cdt-V, provides evidence for this notion. It also has to be mentioned that, so far, CDT-V is the only established virulence factor with its genes inserted into the TO region of P2-like prophages. In complete P2-like prophage sequences available in GenBank, the TO region is usually occupied by a gene coding for a hypothetical protein, or in the case of EHEC O157:H7 strain TW14359, the genes of a putative virulence factor, one of which shows partial homology to a eukaryotic serine esterase and a gene of Bacillus amyloliquefaciens (30). Genes encoding reverse transcriptases have been also reported in the TO regions of P2-like prophages found in the genomes of ECOR strains (31). The foreign origin of the cdt-V operon is also supported by the considerable difference between the GC content of the operon and the prophage (41% versus 53%).

The fact that no phages were detected from any of the induced cdt-V-positive strains, neither by induction with UV light, mitomycin C, or norfloxacin, is in harmony with current knowledge that P2-like phages are classified as noninducible in E. coli (26). This finding also suggests that the inducible prophages found in STEC strains (19) may represent an earlier evolutionary stage of the cdt-V-carrying P2-like prophages in E. coli and that the phages, which we were unable to induce, could have become temperated by adapting to the host organism.

The P2-like prophage sequences seem to be characteristic for the CDT-V-positive strains, with few differences that can be attributed to the adaptation processes in the various hosts. The presence of the L-413C-like C gene in the stx- and eae-negative O157 CDT-V strains, relative to EHEC CDT-V strains, can be explained with the high variability of this gene, which therefore can be used as a marker to identify and distinguish different P2-like phage variants (26). Our results suggest that while the stx-negative cdt-V O157:H43 strains uniformly contain a P2-like variant with an L-413C-like C gene, the P2-like prophages in the other strains may carry different variants of this gene, as they represent other evolutionary lineages of P2-like phages. It will be an important future task to evaluate whether different P2-like bacteriophage variants may be associated with individual E. coli clonal groups and/or with different virulence factors in their TO region. An interesting finding was the carriage of P2-like genes by strain 28C, an extraintestinal pathogenic E. coli strain, which harbors the cdt-IV operon flanked by lambda phage-like genes (14). This observation may indicate that the P2-like genes could be located elsewhere in the E. coli 28C genome. Alternatively, recombination between a P2-like and a lambdoid phage cannot be excluded. Another example of P2-like phages serving as vehicles for foreign DNA can apparently be found in the CDT-negative atypical O157:NM strain B47, which also carries most of the P2-like prophage genes investigated and is where the integration site between cpxP and fieF also seems to be occupied. Strain B47 probably also carries a nearly complete P2-like prophage similar to other investigated O157 CDT-V strains, with as-yet-unknown genes inserted into its integration hot spots. On the other hand, the PCRs specific for the integration site of the P2-like prophage were negative in the case of the O157:NM EHEC strains, suggesting a different integration site for the prophage in these isolates. The atypical O157 strains harboring P2-like genes are phylogenetically distinct from those that do not carry them. While the CDT-negative O157 strains (T4, B20, and B54; all representing the O157:H12 serotype) belong to phylogenetic group A, the CDT-positive O157 strains (T22, T16, T34, T49, T50), as well as strain B47, belong to phylogenetic group B1 (Table 1) (32).

It has been proposed that the presence of P2-like phage sequences suggests the common acquisition of the cdt-V operon in O157:NM EHEC strains after the lineage has diverged from the O157:H7 strains (12). While there is indeed a strong association between O157:NM strains and the presence of CDT-V (17, 19, 33), several strains from other serotypes, both from healthy cattle (23, 33) and from cases of human diarrhea (15, 16, 17, 34), express CDT-V. These findings, together with the results of our study, indicate that while the cdt-V genes are rather conserved, the carrier P2-like phages became diverse during the evolution of their hosts, and this event in most cases may have resulted in loss of their mobility. These facts suggest a more diverse evolutionary and/or transductional history of the cdt-V operon and its carrying of P2-like prophages. The highly conserved cdt-V operon within more variable and potentially inactivated bacteriophage genomes may result from selective pressure to maintain a functional cdt gene cluster and to stabilize this cargo determinant by inactivation of this bacteriophage genome. Further investigations of flanking regions and P2-like prophage sequences in CDT-V-positive strains are expected to help in clarifying the evolutionary background of the distribution of these variants.

ACKNOWLEDGMENT

This work was supported by the Hungarian Research Foundation (OTKA), grant number K 81252. U.D. was supported by the German Research Foundation (DO 789/4-1; SFB1009 TP B05).

Footnotes

Published ahead of print 14 June 2013

REFERENCES

  • 1. Nougayrède J, Taieb F, De Rycke J, Oswald E. 2005. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 13:103–110 [DOI] [PubMed] [Google Scholar]
  • 2. Oswald E, Nougayrède J, Taieb F, Sugai M. 2005. Bacterial toxins that modulate host cell-cycle progression. Curr. Opin. Microbiol. 8:83–91 [DOI] [PubMed] [Google Scholar]
  • 3. Jinadasa RN, Bloom SE, Weiss RS, Duhamel GE. 2011. Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology 157:1851–1875 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Scott DA, Kaper JB. 1994. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect. Immun. 62:244–251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Nesić D, Hsu Y, Stebbins CE. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429–433 [DOI] [PubMed] [Google Scholar]
  • 6. Pérès SY, Marchès O, Daigle F, Nougayrède JP, Herault F, Tasca C, De Rycke J, Oswald E. 1997. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 24:1095–1107 [DOI] [PubMed] [Google Scholar]
  • 7. Comayras C, Tasca C, Pérès SY, Ducommun B, Oswald E, De Rycke J. 1997. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect. Immun. 65:5088–5095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Bielaszewska M, Sinha B, Kuczius T, Karch H. 2005. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect. Immun. 73:552–562 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Johnson WM, Lior H. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb. Pathog. 4:103–113 [DOI] [PubMed] [Google Scholar]
  • 10. Pickett CL, Cottle DL, Pesci EC, Bikah G. 1994. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 62:1046–1051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Tóth I, Hérault F, Beutin L, Oswald E. 2003. Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type IV). J. Clin. Microbiol. 41:4285–4291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Janka A, Bielaszewska M, Dobrindt U, Greune L, Schmidt MA, Karch H. 2003. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H− and O157:H7: characterization and evolutionary considerations. Infect. Immun. 71:3634–3638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Asakura M, Hinenoya A, Alam MS, Shima K, Zahid SH, Shi L, Sugimoto N, Ghosh AN, Ramamurthy T, Faruque SM, Nair GB, Yamasaki S. 2007. An inducible lambdoid prophage encoding cytolethal distending toxin (Cdt-I) and a type III effector protein in enteropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 104:14483–14488 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Tóth I, Nougayrède JP, Dobrindt U, Ledger TN, Boury M, Morabito S, Fujiwara T, Sugai M, Hacker J, Oswald E. 2009. Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect. Immun. 77:492–500 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Bielaszewska M, Fell M, Greune L, Prager R, Fruth A, Tschäpe H, Schmidt MA, Karch H. 2004. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect. Immun. 72:181–186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Hinenoya A, Naigita A, Ninomiya K, Asakura M, Shima K, Seto K, Tsukamoto T, Ramamurthy T, Faruque SM, Yamasaki S. 2009. Prevalence and characteristics of cytolethal distending toxin-producing Escherichia coli from children with diarrhea in Japan. Microbiol. Immunol. 53:206–215 [DOI] [PubMed] [Google Scholar]
  • 17. Friedrich AW, Lu S, Bielaszewska M, Prager R, Bruns P, Xu J, Tschäpe H, Karch H. 2006. Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J. Clin. Microbiol. 44:1844–1846 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Osek J. 2005. Detection of cytolethal distending toxin genes in Shiga toxin-producing Escherichia coli isolated from different sources. Bull. Vet. Inst. Pulawy 49:153–156 [Google Scholar]
  • 19. Allué-Guardia A, García-Aljaro C, Muniesa M. 2011. Bacteriophage encoding cytolethal distending toxin type V gene induced from nonclinical Escherichia coli isolates. Infect. Immun. 79:3262–3272 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Kim J, Kim J, Choo Y, Jang H, Choi Y, Chung J, Cho S, Park M, Lee B. 2009. Detection of cytolethal distending toxin and other virulence characteristics of enteropathogenic Escherichia coli isolates from diarrheal patients in Republic of Korea. J. Microbiol. Biotechnol. 19:525–529 [DOI] [PubMed] [Google Scholar]
  • 21. Birnboim HC, Doly J. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513–1523 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Hertman I, Luria SE. 1967. Transduction studies on the role of a rec+ gene in the ultraviolet induction of prophage lambda. J. Mol. Biol. 23:117–133 [DOI] [PubMed] [Google Scholar]
  • 23. Tóth I, Schmidt H, Kardos G, Lancz Z, Creuzburg K, Damjanova I, Pászti J, Beutin L, Nagy B. 2009. Virulence genes and molecular typing of different groups of Escherichia coli O157 strains in cattle. Appl. Environ. Microbiol. 75:6282–6291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Larina VS, Anisimov PI, Adamov AK. 1970. A novel strain of plague bacteriophage for identification of Pasteurella pestis. Probl. Particularly Dangerous Infect. 11:132–136 [Google Scholar]
  • 25. Garcia E, Chain P, Elliott JM, Bobrov AG, Motin VL, Kirillina O, Lao V, Calendar R, Filippov AA. 2008. Molecular characterization of L-413C, a P2-related plague diagnostic bacteriophage. Virology 372:85–96 [DOI] [PubMed] [Google Scholar]
  • 26. Nilsson AS, Haggård-Ljungquist E. 2007. Evolution of P2-like phages and their impact on bacterial evolution. Res. Microbiol. 158:311–317 [DOI] [PubMed] [Google Scholar]
  • 27. Nilsson AS, Karlsson JL, Haggård-Ljungquist E. 2004. Site-specific recombination links the evolution of P2-like coliphages and pathogenic bacteria. Mol. Biol. Evol. 21:1–13 [DOI] [PubMed] [Google Scholar]
  • 28. Asadulghani M, Ogura Y, Ooka T, Itoh T, Sawaguchi A, Iguchi A, Nakayama K, Hayashi T. 2009. The defective prophage pool of Escherichia coli O157: prophage-prophage interactions potentiate horizontal transfer of virulence determinants. PLoS Pathog. 5:e10000408. 10.1371/journal.ppat.1000408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Sváb D, Horváth B, Szűcs A, Maróti G, Tóth I. 2013. Draft genome sequence of an Escherichia coli O157:H43 strain isolated from cattle. Genome Announc. 1:e00263–13. 10.1128/genomeA.00263-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Kulasekara BR, Jacobs M, Zhou Y, Wu Z, Sims E, Saenphimmachak C, Rohmer L, Ritchie JM, Radey M, McKevitt M, Freeman TL, Hayden H, Haugen E, Gillett W, Fong C, Chang J, Beskhlebnaya V, Waldor MK, Samadpour M, Whittam TS, Kaul R, Brittnacher M, Miller SI. 2009. Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence. Infect. Immun. 77:3713–3721 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Odegrip R, Nilsson AS, Haggård-Ljungquist E. 2006. Identification of a gene encoding a functional reverse transcriptase within a highly variable locus in the P2-like coliphages. J. Bacteriol. 188:1643–1647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Sváb D, Tóth I. 2012. Allelic types of long polar fimbriae in bovine and human Escherichia coli. O157 strains. Acta Vet. Hung. 60:1–15 [DOI] [PubMed] [Google Scholar]
  • 33. Orth D, Grif K, Dierich MP, Würzner R. 2006. Cytolethal distending toxins in Shiga toxin-producing Escherichia coli: alleles, serotype distribution and biological effects. J. Med. Microbiol. 55:1487–1492 [DOI] [PubMed] [Google Scholar]
  • 34. Bielaszewska M, Stoewe F, Fruth A, Zhang W, Prager R, Brockmeyer J, Mellmann A, Karch H, Friedrich AW. 2009. Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates. J. Clin. Microbiol. 47:2061–2066 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. De Rycke J, Plassiart G. 1990. Toxic effects for lambs of cytotoxic necrotising factor from Escherichia coli. Res. Vet. Sci. 49:349–354 [PubMed] [Google Scholar]
  • 36. Karch H, Böhm H, Schmidt H, Gunzer F, Aleksic S, Heesemann J. 1993. Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H−. J. Clin. Microbiol. 31:1200–1205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Iguchi A, Thomson NR, Ogura Y, Saunders D, Ooka T, Henderson IR, Harris D, Asadulghani M, Kurokawa K, Dean P, Kenny B, Quail MA, Thurston S, Dougan G, Hayashi T, Parkhill J, Frankel G. 2009. Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J. Bacteriol. 191:347–354 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Hayashi T, Makino K, Ohnishi M, Kurokawa K, Ishii K, Yokoyama K, Han CG, Ohtsubo E, Nakayama K, Murata T, Tanaka M, Tobe T, Iida T, Takami H, Honda T, Sasakawa C, Ogasawara N, Yasunaga T, Kuhara S, Shiba T, Hattori M, Shinagawa H. 2001. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res. 8:11–22 [DOI] [PubMed] [Google Scholar]
  • 39. Appleyard RK. 1954. Segregation of new lysogenic types during growth of a doubly lysogenic strain derived from Escherichia coli K12. Genetics 39:440–452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Woodcock DM, Crowther PJ, Doherty J, Jefferson S, DeCruz E, Noyer-Weidner M, Smith SS, Michael MZ, Graham MW. 1989. Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res. 17:3469–3478 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES